Institut Gustave Roussy competitive analysis

Explore patent oppositions filed by Institut Gustave Roussy against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 15, 2026
Patent NumberTitleApplicantOpposition Date
Chromosome 13-Linked Breast Cancer Susceptibility GeneENDO RECHERCHEJun 10, 2015

Explore Institut Gustave Roussy's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 15, 2026
Patent NumberPublication DateTitleTotal Oppositions
Jan 14, 2026Methods For Diagnosing A Cancer- Or Antibiotics-Induced Dysbiosis And Their Use For Improving Cancer Treatment By Immunotherapy1
Jun 26, 2024Antibody Which Is Directed Against Galectin-9 And Is An Inhibitor Of The Suppressor Activity Of Regulatory T Lymphocytes1
Dec 15, 2021Cytokine Derived Treatment With Reduced Vascular Leak Syndrome2
Oct 9, 2019Combined Pharmaceutical Composition1

Latest PTAB cases involving Institut Gustave Roussy

Discover the latest PTAB cases involving Institut Gustave Roussy, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Institut Gustave Roussy with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 15, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
INSTITUT GUSTAVE ROUSSY IGR - 3 - -
MARGARET DIXON67 - - -
SANOFI7124 - -
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB41 - - -